Fisher & Paykel Healthcare Corporation Limited
Research Fisher & Paykel Healthcare Corporation Limited (FPH.AX) on Bullrun: market cap AUD 23.24B, P/E 56.4, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFPH.AX
- ExchangeAU
- CountryNew Zealand
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyAUD
- Market capAUD 23.24B
- P/E56.4
- Dividend yield1.1%
- Financial periodFY2026
- RevenueNZD 2.31B
- Revenue growth80.3%
- Net incomeNZD 468.50M
- Free cash flowNZD 468.00M
- Gross margin63.7%
Valuation Snapshot
latest market cap is AUD 23.24B; P/E is 56.4; dividend yield is 1.1%.
Peer valuation comparison
Latest P/E is 56.44x versus a Healthcare sector median of 24.73x (128.2% above).
Latest dividend yield is 1.1% versus a Healthcare sector median of 1.81% (39.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | NZD 2.31B | NZD 468.50M | NZD 468.00M | 63.7% | 0.79 | NZD 461.10M | NZD 146.10M | NZD 2.12B |
| FY2025 | NZD 1.28B | NZD 377.20M | NZD 445.60M | 41.4% | 0.64 | NZD 264.50M | NZD 153.30M | NZD 1.89B |
| FY2024 | NZD 1.76B | NZD 132.60M | NZD 90.60M | 60.3% | 0.23 | NZD 82.00M | NZD 189.10M | NZD 1.76B |
| FY2023 | NZD 1.59B | NZD 250.30M | NZD 26.90M | 59.5% | 0.43 | NZD 121.00M | NZD 145.80M | NZD 1.75B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 23.24B | 56.4 | 1.1% | 0.44 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.44 AUD, yield 1.1%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.27 NZD |
| FY2025 | 0.39 NZD |
| FY2024 | 0.38 NZD |
| FY2023 | 0.33 NZD |
About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.
ETFs that hold Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited is one of the ten largest holdings of one ETF that investors in Europe can buy:
| ETF | Weight | TER |
|---|---|---|
| Fidelity Digital Health UCITS ETF USD Acc | 3.41% | 0.50% |
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Fisher & Paykel Healthcare Corporation Limited's market cap?
Fisher & Paykel Healthcare Corporation Limited's market capitalization is AUD 23.24B.
What is Fisher & Paykel Healthcare Corporation Limited's P/E ratio?
Fisher & Paykel Healthcare Corporation Limited's price-to-earnings (P/E) ratio is 56.4.
Does Fisher & Paykel Healthcare Corporation Limited pay a dividend?
Fisher & Paykel Healthcare Corporation Limited has a dividend yield of 1.1%.
What does Fisher & Paykel Healthcare Corporation Limited do?
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.